“Risk of Cytomegalovirus Reactivation in Patients With Immune-Mediated Inflammatory Diseases Undergoing Biologic Treatment: A Real Matter?”. 2016. Reumatismo 68 (3): 144-47. https://doi.org/10.4081/reumatismo.2016.897.